Newsroom

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of AstroNova, Inc. (NASDAQ: ALOT) to Arcline Investment Management for $29.00 per share in cash.Halper Sadeh encourages AstroNova shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether AstroNova and its board of directors...

OLDWICK, N.J.--(BUSINESS WIRE)--U.S. life/annuity insurers’ borrowings from the Federal Home Loan Banks (FHLBs) slowed in 2025, but still grew by 10% year over year, driven predominantly by funding agreements, according to a new AM Best report. The FHLBs are a system of 11 regionally based government-sponsored banks providing liquidity to financial institutions to promote housing and community initiatives. Insurers can gain access to the FHLB if they engage in mortgage lending and purchase FHLB...

GRENOBLE, Frankrijk--(BUSINESS WIRE)--Allegro DVT, leider in Semiconductor Video IPs en Video Compliance Tools, maakt de beschikbaarheid bekend van zijn realtime AV2 Decoder IP geïntegreerd in zijn Pulsar™ D400 Series Multi-Standard Decoding IP. Deze mijlpaal is in lijn met de aankondiging van het bedrijf in september 2025 die de plannen benadrukte om oplossingen te ontwikkelen voor het opkomende AV2-ecosysteem dat zowel video compliance tools als halfgeleider-IP's omspant. Nu de wereldwijde vr...

GRENOBLE, France--(BUSINESS WIRE)--Allegro DVT, le leader dans le domaine des blocs IP (propriété intellectuelle) de semi-conducteurs pour le traitement vidéo et des outils de conformité vidéo, vient d’annoncer la mise à disposition de son IP pour le décodeur AV2 en temps réel, intégrée à son IP de décodage multistandard Pulsar™ (série D400).. Cette étape importante fait suite à l’annonce faite par l’entreprise en septembre 2025, dans laquelle elle soulignait son intention de développer des sol...

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) and Jo Malone London today announced the launch of Scent Scanner, a first-of-its-kind experience available exclusively on Pinterest and rolling out in the US and France. The experience translates the visual preferences people have expressed across their Pinterest boards into personalized Jo Malone London fragrance recommendations. Building on the success of Jo Malone London's AI Scent Advisor, introduced in 2025, Scent Scanne...

NEW YORK--(BUSINESS WIRE)--SharonAI Holdings Inc. (NASDAQ: SHAZ) (“Sharon AI” or “the Company”), a leading Australian Neocloud, today announced a US$1.6 billion private placement financing, comprising: i) a private placement of approximately US$900 million, split between 6,719,896 shares of the Company’s common stock and pre-funded warrants to purchase 6,374,823 shares of the Company’s common stock, and ii) a private placement of US$700 million aggregate principal amount of 4.75% Convertible Se...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies announces pricing of a public offering....

BELLEVUE, Wash.--(BUSINESS WIRE)--Terreno Realty Corporation Acquires Property in Landover, MD for $77.1 Million...

MINNEAPOLIS--(BUSINESS WIRE)--Tennant Company (NYSE: TNC), a world leader in cleaning equipment and solutions, today announced that Richard H. (Rusty) Zay has been appointed Chief Operating Officer, effective July 1, 2026. Zay, currently serving as the organization’s Chief Commercial Officer, has been on the company’s leadership team since 2010. An industry veteran with more than 25 years of experience in sales, marketing, and operations, he previously held leadership roles in other companies,...

TEL AVIV, Israel--(BUSINESS WIRE)--QuantHealth, the leader in AI-powered clinical trial simulation, today announced the appointment of four executives from the world’s top pharmaceutical and AI organizations to its executive team. The additions strengthen QuantHealth's leadership capabilities as predictive simulation emerges as a critical capability for pharmaceutical companies seeking to improve trial design, reduce development risks, and accelerate the delivery of new therapies to patients. J...